3rd Quarter - Report

DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Ensuring full patient access to drug label and package insert information. H.R. 5133, Patients Right to Know Their Medication Act of 2025.

Foreign entity interest: Apex Swiss Holdings Sarl and the other entities listed on Form LD-1, interests are limited to those of direct and indirect parent companies and owners.

LobbyistCovered position, as disclosed
JAMIE ALEXEI GREGORIAN —
KARINA LYNCH —
MAREN MCBRIDE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5133 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.